» Articles » PMID: 33452294

Baseline Local Hemodynamics As Predictor of Lumen Remodeling at 1-year Follow-up in Stented Superficial Femoral Arteries

Overview
Journal Sci Rep
Specialty Science
Date 2021 Jan 16
PMID 33452294
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In-stent restenosis (ISR) is the major drawback of superficial femoral artery (SFA) stenting. Abnormal hemodynamics after stent implantation seems to promote the development of ISR. Accordingly, this study aims to investigate the impact of local hemodynamics on lumen remodeling in human stented SFA lesions. Ten SFA models were reconstructed at 1-week and 1-year follow-up from computed tomography images. Patient-specific computational fluid dynamics simulations were performed to relate the local hemodynamics at 1-week, expressed in terms of time-averaged wall shear stress (TAWSS), oscillatory shear index and relative residence time, with the lumen remodeling at 1-year, quantified as the change of lumen area between 1-week and 1-year. The TAWSS was negatively associated with the lumen area change (ρ = - 0.75, p = 0.013). The surface area exposed to low TAWSS was positively correlated with the lumen area change (ρ = 0.69, p = 0.026). No significant correlations were present between the other hemodynamic descriptors and lumen area change. The low TAWSS was the best predictive marker of lumen remodeling (positive predictive value of 44.8%). Moreover, stent length and overlapping were predictor of ISR at follow-up. Despite the limited number of analyzed lesions, the overall findings suggest an association between abnormal patterns of WSS after stenting and lumen remodeling.

Citing Articles

A systematic review of clinical and biomechanical engineering perspectives on the prediction of restenosis in coronary and peripheral arteries.

Ninno F, Tsui J, Balabani S, Diaz-Zuccarini V JVS Vasc Sci. 2023; 4:100128.

PMID: 38023962 PMC: 10663814. DOI: 10.1016/j.jvssci.2023.100128.


Recommendations for finite element modelling of nickel-titanium stents-Verification and validation activities.

Bernini M, Hellmuth R, Dunlop C, Ronan W, Vaughan T PLoS One. 2023; 18(8):e0283492.

PMID: 37556457 PMC: 10411813. DOI: 10.1371/journal.pone.0283492.


Superficial Femoral Artery Recanalization Using Fiber Optic RealShape Technology.

Klaassen J, van Herwaarden J, Teraa M, Hazenberg C Medicina (Kaunas). 2022; 58(7).

PMID: 35888679 PMC: 9317753. DOI: 10.3390/medicina58070961.


A predictive multiscale model of in-stent restenosis in femoral arteries: linking haemodynamics and gene expression with an agent-based model of cellular dynamics.

Corti A, Colombo M, Rozowsky J, Casarin S, He Y, Carbonaro D J R Soc Interface. 2022; 19(188):20210871.

PMID: 35350882 PMC: 8965415. DOI: 10.1098/rsif.2021.0871.


Multiscale Computational Modeling of Vascular Adaptation: A Systems Biology Approach Using Agent-Based Models.

Corti A, Colombo M, Migliavacca F, Rodriguez Matas J, Casarin S, Chiastra C Front Bioeng Biotechnol. 2021; 9:744560.

PMID: 34796166 PMC: 8593007. DOI: 10.3389/fbioe.2021.744560.


References
1.
Dake M, Ansel G, Jaff M, Ohki T, Saxon R, Smouse H . Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011; 4(5):495-504. DOI: 10.1161/CIRCINTERVENTIONS.111.962324. View

2.
AbuRahma A . When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?. Ann Vasc Dis. 2018; 11(1):25-40. PMC: 5882358. DOI: 10.3400/avd.ra.18-00001. View

3.
Gray B, Buchan J . The Treatment of Superficial Femoral Artery In-Stent Restenosis: The Jury Is Still Out. JACC Cardiovasc Interv. 2016; 9(13):1393-6. DOI: 10.1016/j.jcin.2016.04.029. View

4.
Abdoli S, Katz S, Ochoa C . Long-Term Patency and Clinical Outcomes of Nitinol Stenting for Femoropopliteal Atherosclerotic Disease. Ann Vasc Surg. 2019; 66:566-572. PMC: 8327365. DOI: 10.1016/j.avsg.2019.11.002. View

5.
Mongrain R, Rodes-Cabau J . [Role of shear stress in atherosclerosis and restenosis after coronary stent implantation]. Rev Esp Cardiol. 2006; 59(1):1-4. View